Skip to main navigation Skip to search Skip to main content

In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci

  • T. Lawrence
  • , C. Rotstein
  • , T. R. Beam
  • , E. A. Gorzynski
  • , D. Amsterdam
  • SUNY Buffalo

Research output: Contribution to journalComment/debate

17 Scopus citations

Abstract

The susceptibilities of 316 gram-positive bacteremic isolates to ramoplanin, vancomycin, and teicoplanin and seven other antibiotics were tested. Ramoplanin demonstrated MICs of ≤0.25 μg/ml for at least 99% of Staphylococcus aureus isolates and 100% of coagulase-negative staphylococci tested. For both oxacillin-susceptible and oxacillin-resistant S. aureus and coagulase-negative staphylococci, the activity of ramoplanin surpassed those of both vancomycin and teicoplanin. Ramoplanin and teicoplanin had comparable activities against enterococci and Streptococcus pneumoniae and were superior to vancomycin.

Original languageEnglish
Pages (from-to)896-900
Number of pages5
JournalAntimicrobial Agents and Chemotherapy
Volume37
Issue number4
DOIs
StatePublished - 1993

Fingerprint

Dive into the research topics of 'In vitro activities of ramoplanin, selected glycopeptides, fluoroquinolones, and other antibiotics against clinical bloodstream isolates of gram-positive cocci'. Together they form a unique fingerprint.

Cite this